Powerful new synthetic vaccines to combat epidemics

A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings, published in Science Advances today [Wednesday 25 September], reveal exceptionally promising results for the Chikungunya vaccine candidate, which has been engineered using a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Business and Enterprise, Health, International, Research; Faculty of Life Sciences, Faculty of Life Sciences, School of Biochemistry, Institutes, Bristol BioDesign Institute, Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sci Source Type: news